Bizengri (zenocutuzumab-zbco )

Bizengri (zenocutuzumab-zbco) is a bispecific HER2- and HER3-directed antibody. It is approved for the treatment of:
adult patients with advanced or metastatic non-small cell lung cancer (NSCLC) who have a neuregulin 1 (NRG1) gene fusion, and whose disease has worsened after earlier treatments.
adult patients with advanced or metastatic pancreatic cancer who have a neuregulin 1 (NRG1) gene fusion, and whose disease has progressed after some previous therapies.

Note: This approval is based on how effectively the medicinal product works and how long its effects last. Further approval may depend on confirming its benefits in future clinical studies.

Recommended Dosage: The recommended dosage of Zenocutuzumab-zbco is 750 mg administered as an intravenous (IV) infusion every 2 weeks until there is evidence of disease progression or unacceptable toxicity. Premedicate patients before each infusion of this therapeutic drug as recommended to decrease the potential risk of infusion-related reactions.

• Patients receiving treatment with Bizengri may experience serious infusion-related reactions like rash, chills, fever, or difficulty breathing. Monitor closely during infusion and stop treatment in case serious symptoms develop. Always have emergency medicines available.
• Zenocutuzumab-zbco may cause serious lung problems such as ILD or pneumonitis, which may cause some symptoms like cough or difficulty breathing. In case such symptoms occur, stop the treatment immediately and consult a doctor for further evaluation.
•  Therapy with Bizengri 375 mg/18.75 mL may affect the heart’s pumping ability, which may cause symptoms like shortness of breath, fatigue, or swelling in the legs. Patients with a known history of heart problems should be monitored closely with periodic heart function tests.
• This therapeutic drug may cause harm to an unborn baby in case used during pregnancy. Women should avoid becoming pregnant throughout the treatment and for at least six months after the last dose. Discuss appropriate contraception options with your doctor
• It is not known if this medicine passes into breast milk. Breastfeeding is not recommended during treatment and for 6 months after the last dose to avoid any potential harm to the baby.

What documents are required to import BIZENGRI to India?

BIZENGRI (zenocutuzumab-zbco) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is BIZENGRI available in India?

BIZENGRI (zenocutuzumab-zbco injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Bizengri in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

BIZENGRI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of BIZENGRI (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Bizengri 375 mg/18.75 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source BIZENGRI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Bizengri®?

Zenocutuzumab-zbco is a Generic Name for the trade name drug Bizengri®.

What is the Manufacturer's Name of Bizengri®?

Bizengri® is manufactured by Merus N.V.

Is Bizengri® approved by the FDA?

Yes, Bizengri® is approved by the FDA. Date of first approval: December 4, 2024.

What is the dosage and form of Bizengri® supplied?

Bizengri is supplied in Injection: 375 mg/18.75 mL (20 mg/mL) in a single-dose vial for intravenous use.

What are the most common side effects of Bizengri® injection?

The most common side effects of Bizengri® are dyspnea, rash, diarrhea musculoskeletal pain, vomiting, nausea, fatigue, infusion-related reactions (IRR), constipation, abdominal pain, and edema.

How much does Bizengri® injection cost in India?

Prices of Bizengri 375 mg/18.75 mL mg injections may fluctuate over time because of market dynamics and regulatory changes. To get the most accurate information on Bizengri 375 mg/18.75 mL injections cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Bizengri® injections be available in SAARC countries?

Apart from Gulf countries, Bizengri® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Bizengri® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Bizengri® 375 mg/18.75 mL injections online in India?

Yes, one can buy Bizengri 375 mg/18.75 mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Bizengri® injections through legal channels.

What are the storage conditions of Bizengri® injections?

Store the vials in a refrigerator at 2-8°C (36-46°F) in their original carton to protect them from light. Do not freeze. Do not shake the vials.